The lethal homozygous variant in the ATP1A2 gene is associated with FARIMPD syndrome phenotypes in newborns
Neurogenetics · 2024
DOI: 10.1007/s10048-024-00775-7 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neurogenetics, 2024. Verfasst von Behzad Haj Mohammad Hassani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Hauptthemen laut MEDLINE: Homozygote, Phenotype, Sodium-Potassium-Exchanging ATPase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
- Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. keyanoosh@gmail.com.
- Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. keyanoosh@gmail.com.
ORCID-Profile: Kianoosh Malekzadeh
Zitieren
APA
Haj Mohammad Hassani, B., & Malekzadeh, K. (2024). The lethal homozygous variant in the ATP1A2 gene is associated with FARIMPD syndrome phenotypes in newborns. Neurogenetics. https://doi.org/10.1007/s10048-024-00775-7
Vancouver
Haj Mohammad Hassani B, Malekzadeh K. The lethal homozygous variant in the ATP1A2 gene is associated with FARIMPD syndrome phenotypes in newborns. Neurogenetics. 2024. doi:10.1007/s10048-024-00775-7
BibTeX
@article{HajMohammadHassani2024,
author = {Haj Mohammad Hassani, Behzad and Malekzadeh, Kianoosh},
title = {The lethal homozygous variant in the ATP1A2 gene is associated with FARIMPD syndrome phenotypes in newborns},
journal = {Neurogenetics},
year = {2024},
doi = {10.1007/s10048-024-00775-7}
}
EUVIMED